1999
DOI: 10.1016/s0168-1656(99)00121-2
|View full text |Cite
|
Sign up to set email alerts
|

Diva vaccines that reduce virus transmission

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
110
0
2

Year Published

2003
2003
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 175 publications
(116 citation statements)
references
References 56 publications
1
110
0
2
Order By: Relevance
“…Therefore, our findings of high cell-mediated and humoral responses after infection by the oronasal route reinforce the need to develop new strategies for vaccine improvement, specifically in view of the development of high cell mediated responses in the context of deleted or marker vaccines. Such vaccines are awaited for use under emergency conditions, to allow rapid discrimination between infected and vaccinated pigs [6,31]. Subunit vaccines were recently developed for that purpose [4] but proved to be of moderate efficacy under emergency [7,30].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, our findings of high cell-mediated and humoral responses after infection by the oronasal route reinforce the need to develop new strategies for vaccine improvement, specifically in view of the development of high cell mediated responses in the context of deleted or marker vaccines. Such vaccines are awaited for use under emergency conditions, to allow rapid discrimination between infected and vaccinated pigs [6,31]. Subunit vaccines were recently developed for that purpose [4] but proved to be of moderate efficacy under emergency [7,30].…”
Section: Discussionmentioning
confidence: 99%
“…This makes seroepidemiological surveillance of the disease impossible in enzootic areas where a vaccination program has been or is being implemented. A way to combine both the activities, viz., vaccination and serosurveillance, for the better management of the disease would be the use of DIVA vaccines, which enable differentiation between infected and vaccinated animals [155]. Faris et al [52] conducted cross-sectional epidemiological study followed by vaccination with Nigeria 75/1 vaccine, produced at National Veterinary Institute (NVI) in Debre-Zeit, Ethiopia and postvaccinal serum antibody assessment against PPR in small ruminant population of Awash Fentale District, Afar, Ethiopia, during September 2006-June 2007.…”
Section: Prevention and Controlmentioning
confidence: 99%
“…A number of inactivated and live attenuated vaccines are commercially available, but the latter are more commonly used because of the requirement for only one vaccine dose (reviewed in [18,19]). A vaccine using a virus containing a deletion of the gene encoding gE is widely used at present; in addition to being highly attenuated, this virus is incapable of reactivation and its use allows differentiation of infected from vaccinated animals based on detection of serological responses to gE [20]. Although live vaccines have proved to be relatively effective, concerns remain about their immunosuppressive activities and some of the most attenuated viruses have been reported to have reduced immunogenicity [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…A vaccine using a virus containing a deletion of the gene encoding gE is widely used at present; in addition to being highly attenuated, this virus is incapable of reactivation and its use allows differentiation of infected from vaccinated animals based on detection of serological responses to gE [20]. Although live vaccines have proved to be relatively effective, concerns remain about their immunosuppressive activities and some of the most attenuated viruses have been reported to have reduced immunogenicity [20,21]. Hence, there is continued interest in the possibility of using subunit antigens for vaccination in some animal production sectors.…”
Section: Introductionmentioning
confidence: 99%